Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
EP1.01 - Advanced NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
EP1.01-21 - Time on Treatment of First-Line PD-1 Inhibitor Monotherapy for Metastatic Non-Small Cell Lung Cancer Patients: Real-World Experience Data
08:00 - 08:00 | Presenter: Nava Siegelmann-Danieli | Author(s): Lior Apter, Sarah Sharman Moser, Sheenu Chandwani, Xin Chen, Varda Shalev, Gabriel Chodick
- Abstract
Loading...
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-15 - Rates of Systemic Anticancer Therapy (SACT) for Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US, 2011–2018
09:45 - 09:45 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading... -
+
P1.16-42 - Real-World Trends in Systemic Anticancer Therapy (SACT) for Squamous Advanced NSCLC (aNSCLC) in the US, 2011–2018
09:45 - 09:45 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading...
-
+
P2.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P2.16-17 - Real-World Trends in Systemic Therapy for Nonsquamous EGFR/ALK-Negative Advanced NSCLC (aNSCLC) in the US, 2011–2018
10:15 - 10:15 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading... -
+
P2.16-41 - Pembrolizumab for Previously Treated, PD-L1–Expressing Advanced NSCLC: Real-World Time on Treatment and Overall Survival
10:15 - 10:15 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading...
